About Penam Laboratories Limited
Data last updated:
Penam Laboratories Limited is a public limited company based in New Delhi, Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 August 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1989PLC037287. Its GSTIN is 07AAACP0362M2ZE (Delhi). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹5.17 Cr. It is led by directors including Surender Kumar Ajmani (Managing Director) and Paras Nath Pandey (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 223 New Rajinder Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2025, the company reported a revenue of ₹407.63 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹39.62 Cr (net margin 9.7%) and EBITDA of ₹54.78 Cr (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
The company has about 192 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Penam Laboratories. As per MCA filings, the company has satisfied charges of ₹61.95 Cr on record. Court records list 26 cases involving the company, including 16 filed by the company and 10 filed against it; 10 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website penam.in.
Company details
Contact details
Penam Laboratories Limited's registered office is in New Delhi, Delhi. Its website is penam.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF – 223 New Rajinder Nagar, New Delhi, Delhi, India – 110060
- IndustryPharma, API Manufacturers
To see the full contact details of Penam Laboratories Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Penam Laboratories operates one associated brand: Penam Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Production of antibiotics, anti-infectives, formulations, and fine chemicals in the pharmaceutical sector. | penam.in |
Business activity
The main business activity of Penam Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Penam Laboratories Limited, buy the company report.
Financials of Penam Laboratories Limited
FY 2025 filings availablePenam Laboratories Limited reported revenue of ₹407.63 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹54.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹39.62 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Penam Laboratories Limited, buy the company report.
Board of directors of Penam Laboratories Limited
Penam Laboratories has 8 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Jain Also directs: Bespoke Health Services Private Limited | Director | 30 Sep 2024 | 2 Years 1 Months | Current |
| Raj Rani Ajmani | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
| Vikas Pandey Also directs: Naptri Impex LLP | Whole-Time Director | 30 Sep 2020 | 6 Years 1 Months | Current |
| Ashish Ajmani | Whole-Time Director | 05 Oct 2009 | 17 Years 0 Months | Current |
| Surender Kumar Ajmani | Managing Director | 07 Aug 1989 | 37 Years 2 Months | Current |
| Abha Pandey | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Penam Laboratories Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Olon Active Pharmaceutical Ingredients India Private Limited | ₹431.21 Cr (FY 2025) | 11.0% | Thane, Maharashtra, India | |||
| Sterling Biotech Limited | ₹428.01 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Senores Pharmaceuticals Limited | ₹417.51 Cr (FY 2025) | 92.0% | Ahmedabad, Gujarat, India | |||
| Themis Medicare Limited | ₹410.18 Cr (FY 2025) | 6.0% | Vapi, Gujarat, India | |||
| Penam Laboratories Limitedthis company | ₹407.63 Cr (FY 2025) | ₹39.62 Cr | 9.7% | -26.0% | 192 | New Delhi, Delhi, India |
| Gland Chemicals Pvt Ltd | ₹401.18 Cr (FY 2022) | 33.0% | Hyderabad, Telangana, India | |||
| Emnar Pharma Private Limited | ₹394.57 Cr (FY 2024) | 1.0% | Sanath Nagar Hyderabad, Telangana, India | |||
| Astec Lifesciences Limited | ₹386.93 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Penam Laboratories Limited, buy the company report.
Auditor
Penam Laboratories Limited is audited by SUBODH JAIN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBODH JAIN & CO | FY 2023 | 002992N |
Shareholding
The shareholding of Penam Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Penam Laboratories Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2013 | 10446773 | Others | ₹16 Cr | Satisfied | |
| 26 Jun 1998 | 80043160 | Statebank of India | ₹21.84 Cr | Satisfied | |
| 26 Aug 1997 | 80043158 | Ifci | ₹6.9 Cr | Satisfied | |
| 29 Jun 1992 | 80043154 | State Bank of Patiala | ₹1.85 Cr | Satisfied | |
| 29 Jun 1992 | 80043155 | State Bank of Patiala | ₹20 Lakh | Satisfied |
To see the full charge records of Penam Laboratories Limited, buy the company report.
Total charge records: 11 View all charges
Legal cases
Penam Laboratories Limited has 26 court cases on record: 16 filed by Penam Laboratories, 10 filed against it. 10 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 6 | 4 |
| High courts | 12 | 3 | 5 |
| Supreme Court | 2 | 1 | 1 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0501-Land Acquisition & Requisition Matters : Matters challenging the acquisition proceedings) | Filed against the company by Haryana State Industrial and Infrastructure Development Corporation Ltd (Formerly Known As Haryana State Industrial Development Corporation Ltd.) Through Its Divisional Town Planner Plot No C-13/14, Sector 6 ,Panchkula * , Haryana and 2 others | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Ms Mars Remedies Private Ltd | Disposed |
| High Court of Delhi | Appeal | Filed against the company by Air Liquide North India Private Ltd | Disposed |
| District court, Central, Delhi | Civil suit | Filed against the company by Ms Air Liquide North India Private Limited | Disposed |
| District court, Central, Delhi | Civil suit | Filed by the company against Ms Eaco Labs Ltd. | Disposed |
To see the full case history of Penam Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Penam Laboratories Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Penam Laboratories Limited has a workforce of 192 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Penam Laboratories has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACP0362M2ZE | Delhi | Active | 19 Aug 2017 |
| 07AAACP0362M3ZD | Delhi | Active | 28 Dec 2024 |
| 06AAACP0362M1ZH | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Penam Laboratories Limited, buy the company report.
Recent activity
Penam Laboratories Limited has 22 board changes on record since 1989: 9 appointments and 13 cessations. The latest: Arun Mittal ceased to be Director on 30 Sep 2024.
41 earlier events are in the company report.
Frequently asked questions
Penam Laboratories is an active public limited company based in New Delhi, Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 August 1989 (37+ years old) and is registered under CIN U24231DL1989PLC037287.
Penam Laboratories has 8 current directors:
- Surender Kumar Ajmani - Managing Director
- Paras Nath Pandey - Managing Director
- Vikas Pandey - Whole-Time Director
- Ashish Ajmani - Whole-Time Director
- Shweta Jain - Director
- Raj Rani Ajmani - Director
- Abha Pandey - Director
- Pankaj Jain - Director
The latest financial statements of Penam Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Penam Laboratories is 07AAACP0362M2ZE, registered in Delhi. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAACP0362M3ZD (Delhi), 06AAACP0362M1ZH (Haryana).
The CIN (Corporate Identification Number) of Penam Laboratories is U24231DL1989PLC037287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Penam Laboratories has 26 court cases on record: 16 filed by the company and 10 filed against it. 10 are pending. Most are in the district courts.
Penam Laboratories was incorporated on 07 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Penam Laboratories by revenue are Olon Active Pharmaceutical Ingredients India Private Limited, Sterling Biotech Limited, Senores Pharmaceuticals Limited, Themis Medicare Limited, Gland Chemicals Pvt Ltd and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arun Mittal ceased to be Director on 30 Sep 2024. Narinder Mohan Jhanji ceased to be Director on 30 Sep 2024. Pankaj Jain was appointed as Director on 30 Sep 2024. Penam Laboratories has 22 board changes on record in total.
Penam Laboratories can be reached through the website penam.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Penam Laboratories is at F – 223 New Rajinder Nagar, New Delhi, Delhi, India – 110060.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
